203 related articles for article (PubMed ID: 35501111)
1. True Efficacy of LAA Closure: Patient Outcomes on Long-term Single-Antiplatelet or No Therapy: Insights From the EWOLUTION Registry.
Paitazoglou C; Bergmann MW; Ince H; Kische S; Romanov A; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Vireca E; Wohlmuth P; Boersma L;
J Invasive Cardiol; 2022 May; 34(5):E348-E355. PubMed ID: 35501111
[TBL] [Abstract][Full Text] [Related]
2. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
[TBL] [Abstract][Full Text] [Related]
3. Left Atrial Appendage Occlusion in Patients With Anticoagulation Failure vs Anticoagulation Contraindication.
Aarnink EW; Maarse M; Fierro N; Mazzone P; Beneduce A; Tondo C; Gasperetti A; Pracon R; Demkow M; Zieliński K; de Backer O; Korsholm K; Nielsen-Kudsk JE; Estévez-Loureiro R; Caneiro-Queija B; Benito-González T; Pérez de Prado A; Nombela-Franco L; Salinas P; Holmes D; Almakadma AH; Berti S; Romeo MR; Millan X; Arzamendi D; Alla VM; Agarwal H; Eitel I; Paitazoglou C; Freixa X; Cepas-Guillén P; Chothia R; Badejoko SO; Spoon DB; Maddux JT; El-Chami M; Ram P; Branca L; Adamo M; Suradi HS; Peper J; van Dijk VF; Rensing BJWM; Swaans MJ; Vireca E; Bergmann MW; Boersma LVA;
JACC Cardiovasc Interv; 2024 Jun; 17(11):1311-1321. PubMed ID: 38795093
[TBL] [Abstract][Full Text] [Related]
4. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.
Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Mazzone P; Foley D; Grygier M; Sievert H; De Potter T; Vireca E; Stein K; Bergmann MW;
Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006841. PubMed ID: 30939908
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
[TBL] [Abstract][Full Text] [Related]
6. Real-world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy: results of the DAPT subgroup from the EWOLUTION all-comers study.
Bergmann MW; Ince H; Kische S; Schmitz T; Meincke F; Schmidt B; Foley D; Betts TR; Grygier M; Protopopov AV; Stein KM; Boersma LVA
EuroIntervention; 2018 Apr; 13(17):2003-2011. PubMed ID: 29313819
[TBL] [Abstract][Full Text] [Related]
7. Sex-related differences in outcome after left atrial appendage occlusion: Insights from Europe and the EWOLUTION registry.
Paitazoglou C; Eitel I; Stiermaier T; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Vireca E; Wohlmuth P; Lucas B; Bergmann MW;
Catheter Cardiovasc Interv; 2023 Aug; 102(2):283-292. PubMed ID: 37393575
[TBL] [Abstract][Full Text] [Related]
8. Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients With Atrial Fibrillation.
Kapadia SR; Krishnaswamy A; Whisenant B; Potluri S; Iyer V; Aragon J; Gideon P; Strote J; Leonardi R; Agarwal H; Larrain G; Sanchez C; Panaich SS; Harvey J; Vahl T; Menon V; Wolski K; Wang Q; Leon MB
Circulation; 2024 Mar; 149(10):734-743. PubMed ID: 37874908
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study.
Korsholm K; Valentin JB; Damgaard D; Diener HC; Camm AJ; Landmesser U; Hildick-Smith D; Johnsen SP; Nielsen-Kudsk JE
Int J Cardiol; 2022 Sep; 363():56-63. PubMed ID: 35780932
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of short-term anticoagulant regimens after left atrial appendage occlusion: A systematic review and meta-analysis.
Zhou Q; Liu X; Yang X; Huang XH; Wu YZ; Tao YY; Wei M
Thromb Res; 2024 Jan; 233():88-98. PubMed ID: 38035647
[TBL] [Abstract][Full Text] [Related]
11. DAPT Is Comparable to OAC Following LAAC With WATCHMAN FLX: A National Registry Analysis.
Coylewright M; Holmes DR; Kapadia SR; Hsu JC; Gibson DN; Freeman JV; Yeh RW; Piccini JP; Price MJ; Allocco DJ; Nair DG
JACC Cardiovasc Interv; 2023 Nov; 16(22):2708-2718. PubMed ID: 37943200
[TBL] [Abstract][Full Text] [Related]
12. Left atrial appendage occlusion in recurrent ischaemic stroke, a multicentre experience.
Galloo X; Carmeliet T; Prihadi EA; Lochy S; Scott B; Verheye S; Schoors D; Vermeersch P
Acta Clin Belg; 2022 Apr; 77(2):255-260. PubMed ID: 32951514
[TBL] [Abstract][Full Text] [Related]
13. Left atrial appendage occlusion in patients older than 85 years. Safety and efficacy in the EWOLUTION registry.
Cruz-González I; Ince H; Kische S; Schmitz T; Schmidt B; Gori T; Foley D; de Potter T; Tschishow W; Vireca E; Stein K; Boersma LV
Rev Esp Cardiol (Engl Ed); 2020 Jan; 73(1):21-27. PubMed ID: 30956034
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial.
Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Foley D; Sievert H; Mazzone P; De Potter T; Vireca E; Stein K; Bergmann MW;
Heart Rhythm; 2017 Sep; 14(9):1302-1308. PubMed ID: 28577840
[TBL] [Abstract][Full Text] [Related]
15. Left Atrial Appendage Occlusion Versus Oral Anticoagulation in Atrial Fibrillation : A Decision Analysis.
Chew DS; Zhou K; Pokorney SD; Matchar DB; Vemulapalli S; Allen LA; Jackson KP; Samad Z; Patel MR; Freeman JV; Piccini JP
Ann Intern Med; 2022 Sep; 175(9):1230-1239. PubMed ID: 35969865
[TBL] [Abstract][Full Text] [Related]
16. Patient-Level Analysis of Watchman Left Atrial Appendage Occlusion in Practice Versus Clinical Trials.
Friedman DJ; Du C; Wang Y; Agarwal V; Varosy PD; Masoudi FA; Holmes DR; Reddy VY; Price MJ; Curtis JP; Freeman JV
JACC Cardiovasc Interv; 2022 May; 15(9):950-961. PubMed ID: 35512918
[TBL] [Abstract][Full Text] [Related]
17. Combining left atrial appendage closure and catheter ablation for atrial fibrillation: 2-year outcomes from a multinational registry.
Phillips KP; Romanov A; Artemenko S; Folkeringa RJ; Szili-Torok T; Senatore G; Stein KM; Razali O; Gordon N; Boersma LVA
Europace; 2020 Feb; 22(2):225-231. PubMed ID: 31665276
[TBL] [Abstract][Full Text] [Related]
18. The ALSTER-FLX Registry: 3-Month outcomes after left atrial appendage occlusion using a next-generation device, a matched-pair analysis to EWOLUTION.
Paitazoglou C; Meincke F; Bergmann MW; Eitel I; Fink T; Vireca E; Wohlmuth P; Veliqi E; Willems S; Markiewicz A; Grygier M
Heart Rhythm; 2022 Jun; 19(6):917-926. PubMed ID: 35181483
[TBL] [Abstract][Full Text] [Related]
19. Residual stroke risk after left atrial appendage closure in patients with prior oral anticoagulation failure.
Pracoń R; Zieliński K; Bangalore S; Konka M; Kruk M; Kępka C; Trochimiuk P; Dębski M; Przyłuski J; Kaczmarska E; Dzielińska Z; Kurowski A; Witkowski A; Demkow M
Int J Cardiol; 2022 May; 354():17-21. PubMed ID: 35219744
[TBL] [Abstract][Full Text] [Related]
20. Initial and long-term antithrombotic therapy after left atrial appendage closure with the WATCHMAN.
Ledwoch J; Sievert K; Boersma LVA; Bergmann MW; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts TR; Mazzone P; Foley D; Grygier M; De Potter T; Sievert H;
Europace; 2020 Jul; 22(7):1036-1043. PubMed ID: 32464648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]